FH and metabolic disease: Thus, metabolic disorder due to mutations in metabolic genes, such as isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase, could reduce TET enzymatic activity, leading to the impairment of DNA hydroxymethylation, and could contribute to cancer progression [37,38].